Henrik Sejersen, Clinical Optometrist and VISICORT researcher at the Department of Ophthalmology, University Hospital Aarhus took to the road to visit clinical trial sites undertaking the recruitment and execution of VISICORT’s clinical studies. This VISICORT clinical study monitor tour resulted from a lively discussion at the most recent plenary meeting hosted by the University of Bristol on the 26th and 27th of October 2017. One resulting action item from the meeting entailed visits by Henrik to four clinical trial sites with a view to promoting the completeness and accuracy of clinical data on the cross-sectional and longitudinal studies. Remarking on the tour Henrik stated, “It has been a fantastic trip around Europe; a tight schedule with monitoring visits in 4 different countries in 5 days. But it was worth the effort. Together with the local investigators, I went through the majority of the prospective and some cross-sectional patients and compared data from their records with the Vims System. In general, the sites have done a good job, but there were some small variations in the way we type in and analyze our results. That has now been addressed, and the data reliability and accuracy has been increased. Going through that many data I found astounding few mistypes which support the brilliant job the research staff is doing. Each site has now been encouraged to do self-monitoring in the future.”
VISICORT coordinator, Prof. Matthew Griffin of the Regenerative Medicine Institute (REMEDI) at the National University of Ireland, Galway commented: “The VISICORT project is gathering detailed clinical data from new and established corneal transplant recipients at five leading Ophthalmology Centres in Europe. This information will become more and more valuable as time goes by. Of most importance to our research goals, it will allow us to link the molecular signatures in samples taken from the patients early after transplantation to rejection and other harmful events that occur months or years later. We have successfully developed an excellent web-based database that stores this information securely and confidentially. However, accurate and consistent data collection at each site also requires high-level training and dedicated attention to detail from the research teams at each site. Mr Sejersen’s tour of the clinical research sites at Dublin, Bristol, Berlin and Nantes have helped to consolidate the great team spirit that has grown up among the VISICORT researchers involved the project across these sites. This “human touch” element is critical to ensuring that the clinical information gathered throughout the project will be of the highest quality”.
The photos below document the 4-stop tour to the Royal College of Surgeons in Ireland, Dublin, University of Bristol, UK, Charité University Hospital Berlin, and the Institute of Transplantation-Urology- Nephrology at Inserm in Nantes.
Stop one was at the Royal College of Surgeons in Ireland with Diana Malata.
Stop two was at the Department of Clinical Sciences at the University of Bristol with Gemma Brimson.
During stop three at Charité University Hospital Berlin, Henrik reviewed the data with Prof Uwe Pleyer and VISICORT fellow Nina Steinhorst.
The last stop was in Nantes at Inserm’s Institute of Transplantation-Urology- Nephrology. Here, Henrik met with Bertrand Favres, and clinical nurses Catherine Ivan and Adeline Chenu.